Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience

In the treatment of cancer, immune checkpoint inhibitors (ICIs) have demonstrated significantly greater effectiveness compared to conventional cytotoxic or platinum-based chemotherapies. To assess the efficacy of ICI’s in penile squamous cell carcinoma (pSCC) we performed a retrospective observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouvinov, Keren, Mazor, Gal, Kozlener, Ella, Meirovitz, Amichay, Shrem, Noa Shani, Abu Saleh, Omar, Shalata, Sondos, Yakobson, Alexander, Shalata, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672594/
https://www.ncbi.nlm.nih.gov/pubmed/38003938
http://dx.doi.org/10.3390/jpm13111623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672594/
https://www.ncbi.nlm.nih.gov/pubmed/38003938
http://dx.doi.org/10.3390/jpm13111623

Ejemplares similares